Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

High seroreactivity against SARS-CoV-2 Spike epitopes in a pre SARS-CoV-2 cohort: implications for antibody testing and vaccine design

Kaia Palm, Mariliis Jaago, Annika Rähni, Nadežda Pupina, Arno Pihlak, Helle Sadam, Annela Avarlaid, Anu Planken, Margus Planken, Liina Haring, Eero Vasar, Miljana Baćević, France Lambert, Eija Kalso, Pirkko Pussinen, Pentti J. Tienari, Antti Vaheri, Dan Lindholm, Tõnis Timmusk, View ORCID ProfileAmir M Ghaemmaghami
doi: https://doi.org/10.1101/2020.05.18.20105189
Kaia Palm
1Protobios Llc, Tallinn, Estonia. Electronic address:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: amg@nottingham.ac.uk kaia@protobios.com
Mariliis Jaago
1Protobios Llc, Tallinn, Estonia. Electronic address:
2Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kaia@protobios.com
Annika Rähni
1Protobios Llc, Tallinn, Estonia. Electronic address:
2Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kaia@protobios.com
Nadežda Pupina
1Protobios Llc, Tallinn, Estonia. Electronic address:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kaia@protobios.com
Arno Pihlak
1Protobios Llc, Tallinn, Estonia. Electronic address:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kaia@protobios.com
Helle Sadam
1Protobios Llc, Tallinn, Estonia. Electronic address:
2Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kaia@protobios.com
Annela Avarlaid
2Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anu Planken
3North Estonia Medical Centre Foundation, Tallinn, Estonia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margus Planken
3North Estonia Medical Centre Foundation, Tallinn, Estonia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liina Haring
4Institute of Clinical Medicine, University of Tartu, Psychiatry Clinic of Tartu University Hospital, Estonia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eero Vasar
5Department of Physiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia;
6Center of Excellence for Genomics and Translational Medicine, University of Tartu, Tartu, Estonia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miljana Baćević
7Dental Biomaterial Research Unit (d-BRU), Faculty of Medicine, University of Liege, Liege, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
France Lambert
8Department of Periodontology and Oral Surgery, Faculty of Medicine, University of Liege, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eija Kalso
9Department of Anaesthesiology, Intensive Care and Pain Medicine, Helsinki Uiversity Hospital and Department of Pharmacology and SleepWell Research Programme, University of Helsinki, Helsinki, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pirkko Pussinen
10Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pentti J. Tienari
11Department of Neurology, Neurocenter, Helsinki University Hospital, and Translational Immunology Research Program, University of Helsinki, Helsinki, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antti Vaheri
12Department of Virology, Medicum, University of Helsinki, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Lindholm
13Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland;
14Minerva Foundation Institute for Medical Research, Helsinki, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tõnis Timmusk
1Protobios Llc, Tallinn, Estonia. Electronic address:
2Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kaia@protobios.com
Amir M Ghaemmaghami
15Immunology and Immuno-Bioengineering Group, School of Life Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom. Electronic address:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amir M Ghaemmaghami
  • For correspondence: amg@nottingham.ac.uk Amir.Ghaemmaghami@nottingham.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Little is known about the quality of polyclonal antibody responses in COVID-19 patients, and how it correlates with disease severity or patients’ prior exposure to other pathogens. The whole polyclonal antibody repertoire in a retrospective cohort of 538 individuals was mapped against SARS-CoV-2 spike (S) glycoprotein, the main target of antibody immune responses in SARS-CoV-2 infection. Bioinformatic predictions identified 15 major B cell epitopes for S of SARS-CoV-2. Several epitopes localised in RBD of S including those spanning the ACE2-binding site, the highly conserved cryptic epitope of the neutralizing antibody of SARS-CoV, and fusion/entry domains of HR1 and HR2 of S protein of SARS-CoV-2. Intriguingly, some of these epitopes have cross-reactivity to antigens of common pathogens, potentially affecting SARS-CoV-2 infection outcome. High level of anti-Spike SARS-CoV-2 seroreactivity in populations with no history of exposure to SARS-CoV-2 is of clinical relevance and could underpin better understanding of COVID-19 pathophysiology in different populations and provide a blueprint for design of effective vaccines and developing better strategies for antibody testing.

Competing Interest Statement

KP, MJ, AR, NP, HS and AP are employees of Protobios. KP and TT are founders of Protobios, KP serves as member of board of Protobios. AP and KP are inventors on a patent application (PCT Application No. US/14,079626) filed by Protobios, Inc. that covers the use of phage display method to manipulate and monitor humoral immunity. All other authors declare no competing interests.

Funding Statement

This study was supported by institutional research funding grants of Protobios (5.1-4/20/170, and PRG573) from the Estonian Research Council and H2020-MSCA-RISE-2016 (EU734791) from the European Union, Helsinki University Hospital grants, Mary and Georg C. Ehrnroth Foundation, Finnish Eye Foundation. KP, AA, and TT were partially supported by the institutional research grant IUT19-18 of TUT from the Estonian Research Council. This project has also received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement 760921 (PANBioRA).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data that support the findings of this study are available on request from the corresponding author (KP). The data are not publicly available due to containing information that could compromise research participant privacy/consent. Any materials that can be shared will be released via a material transfer agreement.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 22, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
High seroreactivity against SARS-CoV-2 Spike epitopes in a pre SARS-CoV-2 cohort: implications for antibody testing and vaccine design
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
High seroreactivity against SARS-CoV-2 Spike epitopes in a pre SARS-CoV-2 cohort: implications for antibody testing and vaccine design
Kaia Palm, Mariliis Jaago, Annika Rähni, Nadežda Pupina, Arno Pihlak, Helle Sadam, Annela Avarlaid, Anu Planken, Margus Planken, Liina Haring, Eero Vasar, Miljana Baćević, France Lambert, Eija Kalso, Pirkko Pussinen, Pentti J. Tienari, Antti Vaheri, Dan Lindholm, Tõnis Timmusk, Amir M Ghaemmaghami
medRxiv 2020.05.18.20105189; doi: https://doi.org/10.1101/2020.05.18.20105189
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
High seroreactivity against SARS-CoV-2 Spike epitopes in a pre SARS-CoV-2 cohort: implications for antibody testing and vaccine design
Kaia Palm, Mariliis Jaago, Annika Rähni, Nadežda Pupina, Arno Pihlak, Helle Sadam, Annela Avarlaid, Anu Planken, Margus Planken, Liina Haring, Eero Vasar, Miljana Baćević, France Lambert, Eija Kalso, Pirkko Pussinen, Pentti J. Tienari, Antti Vaheri, Dan Lindholm, Tõnis Timmusk, Amir M Ghaemmaghami
medRxiv 2020.05.18.20105189; doi: https://doi.org/10.1101/2020.05.18.20105189

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Allergy and Immunology
Subject Areas
All Articles
  • Addiction Medicine (175)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (171)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8796)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1864)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (493)
  • Hematology (207)
  • HIV/AIDS (396)
  • Infectious Diseases (except HIV/AIDS) (10577)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1762)
  • Nursing (104)
  • Nutrition (267)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (966)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (265)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (221)
  • Psychiatry and Clinical Psychology (1846)
  • Public and Global Health (3992)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (536)
  • Rheumatology (216)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (107)
  • Urology (80)